Scientists from the Helmholtz Centre for Infection Research (HZI) have discovered a class of natural substances that are produced by soil bacteria and prevent somatic cells from dividing. After years of in depth research, the US pharmaceuticals company Bristol Myers Squibb is now launching this agent on the American market as a treatment for cancer. The epothilones that Prof. Gerhard Hofle and Prof. [click link for full article]